Advisory Commission on Childhood Vaccines Meeting, 62861 [2022-22486]

Download as PDF Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2022–22508 Filed 10–14–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines Meeting Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Advisory Commission on Childhood Vaccines (ACCV) provides advice and recommendations to the Secretary of HHS (Secretary) on policy, program development, and other issues related to the implementation of the National Vaccine Injury Compensation Program (VICP) and concerning other matters as described under the Public Health Service Act. To ensure compliance with the statutory requirement that the ACCV meet not less than four times per year, this notice announces that the ACCV meeting originally scheduled for March 3, 2022, has been rescheduled for December 2, 2022. DATES: The ACCV meeting will be held on December 2, 2022, from 1:00 p.m.– 4:00 p.m. Eastern Time. ADDRESSES: This meeting will be held by Zoom webinar. • Webinar link: https://hrsagov.zoomgov.com/j/1603695024? pwd=ZG4rUWw 0NUlTN2d0OWRZWVJjVmNIZz09. • Conference call-in number: 833 568 8864, Meeting ID: 160 369 5024, Passcode: 72471327. FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison, ACCV, 5600 Fishers Lane, Rockville, Maryland 20857, telephone: (301) 945–9386 or email: ACCV@HRSA.gov. SUPPLEMENTARY INFORMATION: All 2022 ACCV meetings were originally announced in the Federal Register, Vol. 87, No. 20 on Monday, January 31, 2022, (FR Doc. 2022–01848 Filed 1–28–22), and the notice canceling the March 3, 2022, meeting was published on February 28, 2022 (FR Doc. 2022–04127 Filed 2–25–22). Since priorities dictate ACCV meeting times, be advised that start times, end times, and agenda items are subject to change. Agenda items may include but lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:35 Oct 14, 2022 Jkt 259001 are not limited to, updates from the Division of Injury Compensation Programs (HRSA), Torts Branch (Department of Justice), Office of Infectious Disease and HIV/AIDS Policy (HHS), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics, Evaluation and Research (Food and Drug Administration). Refer to the ACCV website at https://www.hrsa.gov/ advisory-committees/vaccines/ index.html for all current and updated information concerning the ACCV meeting, including draft agendas and meeting materials that will be posted 5 calendar days before the meeting. The ACCV meeting will be public, and members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to the ACCV should be sent to Pita Gomez using the contact information above at least 5 business days before the meeting date. Individuals who need special assistance or another reasonable accommodation should notify Pita Gomez using the contact information listed above at least 10 business days before the meeting they wish to attend. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2022–22486 Filed 10–14–22; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Health Center Program Forms OMB No. 0915–0285 Revision Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection SUMMARY: PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 62861 Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR. DATES: Comments on this ICR should be received no later than December 16, 2022. Submit your comments to paperwork@hrsa.gov or mail the HRSA Information Collection Clearance Officer, Room 14N136B, 5600 Fishers Lane, Rockville, MD 20857. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, email paperwork@hrsa.gov or call Samantha Miller, the acting HRSA Information Collection Clearance Officer at (301) 443–9094. SUPPLEMENTARY INFORMATION: When submitting comments or requesting information, please include the information request collection title for reference. Information Collection Request Title: Health Center Program Forms, OMB No. 0915–0285 Revision. Abstract: The Health Center Program, administered by HRSA, is authorized under section 330 of the Public Health Service (PHS) Act (42 U.S.C. 254b). Health centers are community-based and patient-directed organizations that deliver affordable, accessible, quality, and cost-effective primary health care services to patients regardless of their ability to pay. Nearly 1,400 health centers operate approximately 14,000 service delivery sites that provide primary health care to more than 30 million people in every U.S. state, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, and the Pacific Basin. HRSA uses forms for new and existing health centers and other entities to apply for various grant and non-grant opportunities, renew grant and nongrant designations, report progress, and change their scopes of project. Need and Proposed Use of the Information: Health Center Programspecific forms are necessary for award processes and oversight of the Health Center Program and other relevant programs. These forms provide HRSA staff and objective review committee panels with information essential for application evaluation, funding recommendation and approval, designation, and monitoring. These forms also provide HRSA staff with information essential for evaluating compliance with Health Center Program statutory and regulatory requirements. ADDRESSES: E:\FR\FM\17OCN1.SGM 17OCN1

Agencies

[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Page 62861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22486]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines Meeting

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Advisory Commission on Childhood Vaccines (ACCV) provides 
advice and recommendations to the Secretary of HHS (Secretary) on 
policy, program development, and other issues related to the 
implementation of the National Vaccine Injury Compensation Program 
(VICP) and concerning other matters as described under the Public 
Health Service Act. To ensure compliance with the statutory requirement 
that the ACCV meet not less than four times per year, this notice 
announces that the ACCV meeting originally scheduled for March 3, 2022, 
has been rescheduled for December 2, 2022.

DATES: The ACCV meeting will be held on December 2, 2022, from 1:00 
p.m.-4:00 p.m. Eastern Time.

ADDRESSES: This meeting will be held by Zoom webinar.
     Webinar link: https://hrsa-gov.zoomgov.com/j/1603695024?pwd=ZG4rUWw0NUlTN2d0OWRZWVJjVmNIZz09.
     Conference call-in number: 833 568 8864, Meeting ID: 160 
369 5024, Passcode: 72471327.

FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison, 
ACCV, 5600 Fishers Lane, Rockville, Maryland 20857, telephone: (301) 
945-9386 or email: [email protected].

SUPPLEMENTARY INFORMATION: All 2022 ACCV meetings were originally 
announced in the Federal Register, Vol. 87, No. 20 on Monday, January 
31, 2022, (FR Doc. 2022-01848 Filed 1-28-22), and the notice canceling 
the March 3, 2022, meeting was published on February 28, 2022 (FR Doc. 
2022-04127 Filed 2-25-22).
    Since priorities dictate ACCV meeting times, be advised that start 
times, end times, and agenda items are subject to change. Agenda items 
may include but are not limited to, updates from the Division of Injury 
Compensation Programs (HRSA), Torts Branch (Department of Justice), 
Office of Infectious Disease and HIV/AIDS Policy (HHS), Immunization 
Safety Office (Centers for Disease Control and Prevention), National 
Institute of Allergy and Infectious Diseases (National Institutes of 
Health) and Center for Biologics, Evaluation and Research (Food and 
Drug Administration). Refer to the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/ for all current 
and updated information concerning the ACCV meeting, including draft 
agendas and meeting materials that will be posted 5 calendar days 
before the meeting.
    The ACCV meeting will be public, and members of the public will 
have the opportunity to provide comments. Public participants may 
submit written statements in advance of the scheduled meeting. Oral 
comments will be honored in the order they are requested and may be 
limited as time allows. Requests to submit a written statement or make 
oral comments to the ACCV should be sent to Pita Gomez using the 
contact information above at least 5 business days before the meeting 
date.
    Individuals who need special assistance or another reasonable 
accommodation should notify Pita Gomez using the contact information 
listed above at least 10 business days before the meeting they wish to 
attend.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-22486 Filed 10-14-22; 8:45 am]
BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.